TickerKhojComparison · NSE · data 2026-11-02
Akums Drugs and Pharmaceuticals Limited vs Anthem Biosciences Limited
In plain words
Size: Anthem Biosciences Limited is about 4.1 times the market value of Akums Drugs and Pharmaceuticals Limited.
Valuation (P/E): Anthem Biosciences Limited 81.7 vs Akums Drugs and Pharmaceuticals Limited 38.3.
Return on equity: Anthem Biosciences Limited 21.7% vs Akums Drugs and Pharmaceuticals Limited 8%.
Profit growth over 3 years: Akums Drugs and Pharmaceuticals Limited 39.1% a year vs Anthem Biosciences Limited 15.4% a year.
Debt to equity: Akums Drugs and Pharmaceuticals Limited 0.05 vs Anthem Biosciences Limited 0.02.
Differences in the numbers, not a recommendation of either stock.
Side by side
| AKUMS | ANTHEM | |
|---|---|---|
| Price | ₹730.3 | ₹829.2 |
| Market cap | ₹11,520 cr | ₹46,685 cr |
| P/E | 38.3 | 81.7 |
| P/B | — | — |
| ROE | 8.0% | 21.7% |
| ROCE | 9.8% | 26.0% |
| Debt / equity | 0.05 | 0.02 |
| Operating margin | 9.1% | 32.7% |
| Dividend yield | 0.14% | 0.24% |
| Sales growth, 3 years (yearly) | 6.0% | 26.2% |
| Profit growth, 3 years (yearly) | 39.1% | 15.4% |
| 1-year return | 55.7% | 15.9% |
| Revenue, last 12 months | ₹4,502 cr | ₹2,002 cr |
| Net profit, last 12 months | ₹292 cr | ₹576 cr |
| Latest quarter | Dec 2025 | Jun 2026 |
| Quarter net profit | ₹66 cr | ₹120 cr |
| Quarter profit vs a year earlier | — | -11.7% |
| Promoter holding | 75.26% | 71.40% |
| Health check | Strong (7.3/10) | Average (5.8/10) |
Common questions
Which has a higher P/E, Akums Drugs and Pharmaceuticals Limited or Anthem Biosciences Limited?
Anthem Biosciences Limited trades at the higher P/E (81.7 against 38.3). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Anthem Biosciences Limited (21.7% against 8.0%).
Which carries more debt?
Akums Drugs and Pharmaceuticals Limited has the higher debt-to-equity ratio (0.05 against 0.02).